Anti-CGRP Monoclonal Antibodies to Prevent Chronic Migraine (2023 Review)
Migraine, a primary headache disorder, significantly impacts the quality of life of millions worldwide. In recent years, the focus has shifted toward developing targeted therapies, particula…
Read article